Methodological quality assessment of meta- analyses and systematic reviews of probiotics in inflammatory bowel disease and pouchitis

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Dong, Jinpei ^a   Teng, Guigen ^a   Wei, Tiantong ^a   Gao, Wen ^a   Wang, Huahong ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; CROHN DISEASE; DATA BASE; DRUG EFFICACY; HUMAN; ILEITIS; INFLAMMATORY BOWEL DISEASE; MAINTENANCE THERAPY; MEDICATION THERAPY MANAGEMENT; META ANALYSIS (TOPIC); METHODOLOGY; PUBLICATION; QUALITY CONTROL; REMISSION; SYSTEMATIC REVIEW (TOPIC); ULCERATIVE COLITIS; INFLAMMATORY BOWEL DISEASES; META ANALYSIS; POUCHITIS; STANDARDS;

HUMANS; INFLAMMATORY BOWEL DISEASES; POUCHITIS; PROBIOTICS; PUBLICATIONS; REMISSION INDUCTION;

EID: 85007376172     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168785     Document Type: Article

References (48)

1. de Moreno de LeBlanc A, Del Carmen S. Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models. 2015; 2015:146972.
2. Basso PJ, Fonseca MT, Bonfa G, Alves VB, Sales-Campos H, Nardini V, et al. Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2014; 47(9):727-37. doi: 10.1590/1414-431X20143932 PMID: 25075576
3. The Medical Research Library of Brooklyn. The Evidence Pyramid. 2004. Available from: http://library. downstate.edu/EBM2/2100.htm.
4. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC medical research methodology. 2007; 7:10. doi: 10.1186/1471-2288-7-10 PMID: 17302989
5. Canadian Agency for Drugs and Technologies in Health (CADTH). Interventions Directed to Consumers. 2011. Available from: www.cadth.caenresourcesrx-for-change.
6. Abdollahi M, Nikfar S, Darvish Damavandi M. Efficacy of antibiotics and probiotics in management of pouchitis; a meta-analysis. Value in Health. 2010; 13(7):A368-A9.
7. Ashraf I, Sohail U, Arif M, Siddique S, Bechtold M, Choudhary A. Probiotic use for management of pouchitis: A systematic review and meta-analysis. American Journal of Gastroenterology. 2014; 109:S677-S8.
8. Doherty GA, Bennett G, Patil S, Cheifetz A, Moss AC. Meta-analysis of probiotics in the prevention of post-operative recurrence of Crohn's disease. Gastroenterology. 2009; 136(5):A772-A3.
9. Gordon M, Farrell M. Probiotics for maintenance of remission in ulcerative colitis: A cochrane systematic review. Inflammatory Bowel Diseases. 2016; 22:S26-S7.
10. Szajewska H, Horvath A, Dziechciarz P. Probiotics, prebiotics and synbiotics in the treatment of inflammatory bowel disease-A systematic review. Pediatria Wspolczesna. 2007; 9(4):266-75.
11. Fujiya M, Ueno N, Kohgo Y. Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials. Clinical journal of gastroenterology. 2014; 7(1):1-13. doi: 10.1007/s12328-013-0440-8 PMID: 26183502
12. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. A meta-analysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: Evidence for prevention of disease relapse and maintenance of remission. Archives of Medical Science. 2008; 4(2):185-90.
13. Nikfar S, Darvish-Damavandi M, Abdollahi M. A review and meta-analysis of the efficacy of antibiotics and probiotics in management of pouchitis. International Journal of Pharmacology. 2010; 6(6):826-35.
14. Shen J, Ran HZ, Yin MH, Zhou TX, Xiao DS. Meta-analysis: The effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease. Internal Medicine Journal. 2009; 39 (2):103-9. doi: 10.1111/j.1445-5994.2008.01791.x PMID: 19220543
15. Zigra PI, Maipa VE, Alamanos YP. Probiotics and remission of ulcerative colitis: A systematic review. Netherlands Journal of Medicine. 2007; 65(11):411-8. PMID: 18079563
16. Rahimi R, Nikfar S, Rahimi F, Elahi B, Derakhshani S, Vafaie M, et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Digestive diseases and sciences. 2008; 53(9):2524-31. doi: 10.1007/s10620-007-0171-0 PMID: 18270836
17. Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014; 20(1):21-35. doi: 10.1097/01.MIB.0000437495.30052.be PMID: 24280877
18. Doherty GA, Bennett GC, Cheifetz AS, Moss AC. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative Crohn's disease. Alimentary pharmacology & therapeutics. 2010; 31 (8):802-9.
19. Elahi B, Nikfar S, Derakhshani S, Vafaie M, Abdollahi M. On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Digestive diseases and sciences. 2008; 53(5):1278-84. doi: 10.1007/s10620-007-0006-z PMID: 17940902
20. Mardini HE, Grigorian AY. Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis. Inflamm Bowel Dis. 2014; 20(9):1562-7. doi: 10.1097/MIB. 0000000000000084 PMID: 24918321
21. Butterworth AD, Thomas AG, Akobeng AK. Probiotics for induction of remission in Crohn's disease. The Cochrane database of systematic reviews. 2008;(3):Cd006634. doi: 10.1002/14651858. CD006634.pub2 PMID: 18646162
22. Mallon P, McKay D, Kirk S, Gardiner K. Probiotics for induction of remission in ulcerative colitis. The Cochrane database of systematic reviews. 2007;(4):Cd005573. doi: 10.1002/14651858.CD005573. pub2 PMID: 17943867
23. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. The Cochrane database of systematic reviews. 2006;(4):Cd004826. doi: 10.1002/14651858. CD004826.pub2 PMID: 17054217
24. Naidoo K, Gordon M, Fagbemi AO, Thomas AG, Akobeng AK. Probiotics for maintenance of remission in ulcerative colitis. The Cochrane database of systematic reviews. 2011;(12):Cd007443. doi: 10.1002/ 14651858.CD007443.pub2 PMID: 22161412
25. Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs. 2012; 72(6):803-23. doi: 10. 2165/11632710-000000000-00000 PMID: 22512365
26. Sang LX, Chang B, Zhang WL, Wu XM, Li XH, Jiang M. Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis. World journal of gastroenterology. 2010; 16(15):1908-15. doi: 10.3748/wjg.v16.i15.1908 PMID: 20397271
27. Ghouri YA, Richards DM, Rahimi EF, Krill JT, Jelinek KA, DuPont AW. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clinical and experimental gastroenterology. 2014; 7:473-87. doi: 10.2147/CEG.S27530 PMID: 25525379
28. Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. BioMed research international. 2015; 2015:505878. doi: 10.1155/2015/505878 PMID: 25793197
29. Losurdo G, Iannone A, Contaldo A, Ierardi E, Di Leo A, Principi M. Escherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysis. Journal of gastrointestinal and liver diseases: JGLD. 2015; 24(4):499-505. doi: 10.15403/jgld.2014.1121.244.ecn PMID: 26697577
30. Dai ZJ, Tan QH, Li XH. Effect of probiotics on inducing remission of mild to moderate ulcerative colitis in China: a Meta-analysis. Chin J Clinicians (Electronic Edition). 2014;(07):1303-8.
31. Lu J, Wu JX. Evaluation of Probiotics on the Maintenance of Remission in Ulcerative Colitis. J Clin Intern Med. 2009; 26(1):32-5.
32. Niu XP, Han Z, Liu SF. The effect of probiotics in maintaining remission of ulcerative colitis: a meta analysis. Chin J Microbiol. 2010; 22(3):261-3.
33. Hu ZB, Chen LJ, Teng F, Liu LL, Lu HB. Systematic Evaluation on Medilac-S Combined Conventional Treatment for Ulcerative Colitis. Chin Pharm. 2013; 22(7):3-7.
34. Chen RH, Li YF, Yang X, Xia B. Therapeutic Effect of Probiotic Agents on Ulcerative Colitis: A Systematic Review. Chin J Gastroenterol. 2012; 17(4):221-5.
35. Wu QR, Zhou J, He JD, Wang YP, Yang XR, Zhang L. Probiotic Agents for Ulcerative Colitis: A Systematic Review. Chin J Evid-based Med. 2008; 8(5):315-21.
36. Ye K, Wang HL, Liao WF, Zeng FY. Probiotics as an ulcerative colitis in remission induction and drug maintenance treatment: a meta-analysis. J China-Japan Friendship Hosp. 2014; 28(5):288-92.
37. Ma JC, Zhang XL. Efficacy of probiotic agents in maintaining remission of ulcerative colitis: a meta analysis. Shi Jie Hua Ren Xiao Hua Za Zhi. 2008; 16(36):4123-7.
38. Tang SH, Feng SF, Yao YF. Effect of probiotic preparations on inducing and mainfaining remission of ulcerative colitis:a meta-analysis. Med J Chin PLA. 2010; 35(5):521-5.
39. Liao ZH. A Meta-analysis for the Treatment Effect of Probioties on Induction of Remission and Maintenance in Patients with Ulcerative Colitis. Thesis, Jinan university. 2010. Available from: http://www.cnki. net/KCMS/detail/detail.aspx?QueryID=2&CurRec=2&recid=&filename=2010124555.nh&dbname= CMFD2010&dbcode=CMFD&pr=&urlid=&yx=&uid=WEEvREcwSlJHSldTTGJhYlNiM3pYYUFuOXFF NndBZmNpaWtrNVJUODR2RGk=$9A4hF-YAuvQ5obgVAqNKPCYcEjKensW4ggI8Fm4gTkoUKaID 8j8gFw!!&v=MTQwMThNMUZyQ1VSTHlmWU9ac0ZDbm1VN3JJVjEyNkhySzZHdFRKcXBFYlBJU jhlWDFMdXhZUzdEaDFUM3FUclc=.
40. Wang XT, Dai JF, Lv B. Probiotics for Induction and Maintenance of Remission in Inflammatory Bowel Disease: A Meta-analysis. Chin J Gastroenterol. 2015; 20(1):29-35.
41. Shen J, Ran ZH, Tong JL, Xiao SD. Effect of probiotics on remission, relapse and pouchitis in inflammatory bowel disease: meta-analysis. Chin J Gastroenterol Hepatol. 2008; 17(2):114-8.
42. Ma XF. Effects of probiotics on remission and relapse in adult ulcerative colitis A meta-analysis. Thesis, Nanjing University of Chinese Medicine. 2013. Available from: http://www.cnki.net/KCMS/detail/detail. aspx?QueryID=0&CurRec=1&recid=&filename=1014416309.nh&dbname=CMFD201501&dbcode= CMFD&pr=&urlid=&yx=&uid=WEEvREcwSlJHSldTTGJhYlNiM3pYYUFuOXFFNndBZmNpaWtrNVJU ODR2RGk=$9A4hF-YAuvQ5obgVAqNKPCYcEjKensW4ggI8Fm4gTkoUKaID8j8gFw!!&v=MTEwMjB GckNVUkx5ZllPWnNGQ25tVmI3SlZGMjZHcmU1R05MTXBwRWJQSVI4ZVgxTHV4WVM3RGgxVD NxVHJXTTE=.
43. Li XM, Li X, Pu FF, Shi L, Hu W. Meta-analysis of the effectiveness of using probiotics in conjunction with aminosalicylic acid on remission induction of ulcerative colitis. Morden Prevent Med. 2014; (24):4439-42.
44. Ding J, Xiong GS, Yang CH, Wu JH. Probiotic Preparation VSL#3 for Induction of Remission in Ulcerative Colitis: A Systematic Review. Chin J Gastroenterol. 2012;(09):521-6.
45. Jin DC, Lu DR, Zhang BJ. Treatment of ulcerative colitis with golden bifid combined with aminosalicylates: a Meta-analysis. Chin J Clinicians(Electronic Edition). 2016;(03):401-5.
46. Zhang QN, Huo LJ, Luo RL, Zhang J. Efficacy and safety of probiotics on mild and moderate activity and remission ulcerative colitis: a meta analysis. Contemporary Med. 2016;(05):4-7.
47. Cornell JE, Laine C. The science and art of deduction: complex systematic overviews. Annals of internal medicine. 2008; 148(10):786-8. PMID: 18490692
48. Sharif MO, Janjua-Sharif FN, Ali H, Ahmed F. Systematic reviews explained: AMSTAR-how to tell the good from the bad and the ugly. Oral health and dental management. 2013; 12(1):9-16. PMID: 23474576